Prevalence, incidence and mortality of inflammatory bowel disease in Catalonia. A population-based analysis

References

• Abraham C, Cho JH. Inflammatory Bowel Disease. N Engl J Med. 2009;361:2066–2078.
   PubMed Web of Science ®Google Scholar
• Burisch J, Kiudelis G, Kupcinskas L, et al. Natural disease course of Crohn’s disease during the first 5 years after diagnosis in a European population-based inception cohort: an Epi-IBD study. Gut. 2018. doi:10.1136/gutjnl-2017-315568
   Google Scholar
• Burisch J, Munkholm P. The epidemiology of inflammatory bowel disease. Scand J Gastroenterol. 2015;50:942–951.
   PubMed Web of Science ®Google Scholar
• Burisch J, Jess T, Martinato M, et al. The burden of inflammatory bowel disease in Europe. J Crohns Colitis. 2013;7:322–337.
   PubMed Web of Science ®Google Scholar
• Molodecky NA, Soon IS, Rabi DM, et al. Increasing incidence and prevalence of the inflammatory bowel diseases with time, based on systematic review. Gastroenterol. 2012;142:46–54.e42.
   PubMed Web of Science ®Google Scholar
• Prideaux L, Kamm MA, De Cruz PP, et al. Inflammatory bowel disease in Asia: a systematic review. J Gastroenterol Hepatol. 2012;27:1266–1280.
   PubMed Web of Science ®Google Scholar
• Kaplan GG, Ng SC. Understanding and preventing the global increase of inflammatory Bowel Disease. Gastroenterol. 2017;152:313–321.e2.
   PubMed Web of Science ®Google Scholar
• Pajares JM, Gisbert JP. Epidemiology of inflammatory bowel disease in Spain. A systematic review. Rev Esp Enferm Dig. 2001;93:9–20.
   PubMed Web of Science ®Google Scholar
• Ng SC, Shi HY, Hamidi N, et al. Worldwide incidence and prevalence of inflammatory bowel disease in the 21st century: a systematic review of population-based studies. The Lancet. 2017;390:2769–2778.
   PubMed Web of Science ®Google Scholar
• Farré N, Vela E, Clèries M, et al. Medical resource use and expenditure in patients with chronic heart failure: a population-based analysis of 88 195 patients. Eur J Heart Fail. 2016;18:1132–1140.
   PubMed Web of Science ®Google Scholar
• Population on 1 January. Provinces. IDESCAT: Web de la estadística ofical de Catalunya. Generalitat de Catalunya. Institud de Estadística de Catalunya. 2016. Available from: https://www.idescat.cat/pub/?id=aec&n=245&lang=es
   Google Scholar
• Observatori del Sistema de Salut de Catalunya. Desigualtats Socioeconòmiques en la Salut i la Utilització de Serveis Sanitaris Públics en la Població de Catalunya. Observatori Sobre Els Efectes de la Crisi en la Salut de la Població. Barcelona: Agència de Qualitat i Avaluació Sanitàries de Catalunya. Departament de Salut. Generalitat de Catalunya; 2017.
   Google Scholar
• Von Elm E, Altman DG, Egger M, STROBE Initiative, et al. The Strengthening the reporting of observational studies in epidemiology (STROBE) statement: guidelines for reporting observational studies. PLoS Med. 2007;4:e296–e297.
   PubMed Web of Science ®Google Scholar
• Saro Gismera C, Lacort Fernández M, Argüelles Fernández G, et al. Epidemiology of chronic inflammatory bowel disease in Gijón, Asturias. Gastroenterol Hepatol. 2001;24:228–235.
   PubMedGoogle Scholar
• Saro Gismera C, Riestra Menéndez S, Milla Crespo a, et al. Incidencia y prevalencia en enfermedad inflamatoria intestinal crónica: estudio asturiano en cinco áreas (EIICEA). España. An Med Interna (Madrid). 2003;20:3–9.
   PubMedGoogle Scholar
• Fern´ndez A, Hern´ndez, Martínez-Ares D, et al. Incidence and phenotype at diagnosis of inflammatory bowel disease. Results in Spain of the EpiCom study. Gastronterol Hepatol. 2015;38:534–540.
   PubMed Web of Science ®Google Scholar
• Burisch J, Pedersen N, Čuković-Čavka S, et al. East-West gradient in the incidence of inflammatory bowel disease in Europe: the ECCO-EpiCom inception cohort. Gut. 2014;63:588–597.
   PubMed Web of Science ®Google Scholar
• Garrido a, Martínez MJ, Ortega J. a, et al. Epidemiology of chronic inflammatory bowel disease in the Northern area of Huelva. Rev Esp Enferm Dig. 2004;96:687–691.
   PubMed Web of Science ®Google Scholar
• Arin Letamendia A, Borda Celaya F, Jesús Burusco Paternain M, et al. Altas tasas de incidencia de enfermedad inflamatoria intestinal en Navarra. Resultados de un estudio prospectivo y poblacional. Gastroenterol Hepatol. 2008;31:111–116.
   PubMedGoogle Scholar
• López-Serrano P, Pérez-Calle JL, Carrera-Alonso E, et al. Epidemiologic study on the current incidence of inflammatory bowel disease in Madrid. Rev Esp Enferm Dig. 2009;101:768–772.
   PubMed Web of Science ®Google Scholar
• Lucendo AJ, Hervías D, Roncero Ó, et al. Epidemiology and temporal trends (2000–2012) of inflammatory bowel disease in adult patients in a central region of Spain. Eur J Gastroenterol Hepatol. 2014;26:1399–1407.
   PubMed Web of Science ®Google Scholar
• Bewtra M, Kaiser LM, TenHave T, et al. Crohn’s disease and ulcerative colitis are associated with elevated standardized mortality ratios: a meta-analysis. Inflamm Bowel Dis. 2013;19:599–613.
   PubMed Web of Science ®Google Scholar
• Jess T, Gamborg M, Munkholm P, et al. Overall and cause-specific mortality in ulcerative colitis: meta-analysis of population-based inception cohort studies. Am J Gastroenterol. 2007;102:609–617.
   PubMed Web of Science ®Google Scholar